Financials data is unavailable for this security.
View more
Year on year Genomtec SA had revenues fall -97.50% from 40.00k to 1.00k, though the company grew net income from a loss of 11.93m to a smaller loss of 9.01m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -68.62% |
---|---|
Return on equity | -226.95% |
Return on investment | -107.95% |
More ▼
Cash flow in PLNView more
In 2023, Genomtec SA did not generate a significant amount of cash. Cash Flow from Financing totalled 11.80m or 1,179,800.00% of revenues. In addition the company used 7.95m for operations while cash used for investing totalled 3.80m.
Cash flow per share | -0.6791 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4604 |
---|---|
Tangible book value per share | -0.1362 |
More ▼
Balance sheet in PLNView more
Current ratio | 1.12 |
---|---|
Quick ratio | 1.12 |
Total debt/total equity | 0.2601 |
---|---|
Total debt/total capital | 0.2064 |
More ▼